Yangbo Hu

Evaluation of rare but severe immune related adverse effects in PD-1 and PD-L1 inhibitors in non-small cell lung cancer: a meta-analysis

Yangbo Hu, Qun Zhang, Huijuan Li et al. · Translational Lung Cancer Research · 2017 · 140 citations · Full text

Medicine, Oncology, Pharmacology +15

The clinicopathological and prognostic significance of PD-L1 expression assessed by immunohistochemistry in lung cancer: a meta-analysis of 50 studies with 11,383 patients

Huijuan Li, Yangyang Xu, Bing Wan et al. · Translational Lung Cancer Research · 2019 · 78 citations · Full text

Medicine, Cancer Biology, Oncology +17

<scp>TEAD</scp>4 exerts pro‐metastatic effects and is negatively regulated by miR6839‐3p in lung adenocarcinoma progression

Qun Zhang, Hang Fan, Qian Zou et al. · Journal of Cellular and Molecular Medicine · 2018 · 42 citations · Full text

Medicine, Cancer Biology, Oncology +17

RNA sequencing enables systematic identification of platelet transcriptomic alterations in NSCLC patients

Qun Zhang, Huan Hu, Hongda Liu et al. · Biomedicine & Pharmacotherapy · 2018 · 24 citations

Medicine, Hematology, Molecular Biology +9

Topotecan alleviates ventilator-induced lung injury via NF-κB pathway inhibition

Bing Wan, Wujian Xu, Ping Zhan et al. · Cytokine · 2018 · 21 citations

Medicine, Molecular Medicine, Pathobiology +14